Cargando…

Immune targets for therapeutic development in depression: towards precision medicine

Over the past two decades, compelling evidence has emerged indicating that immune mechanisms can contribute to the pathogenesis of major depressive disorder (MDD) and that drugs with primary immune targets can improve depressive symptoms. Patients with MDD are heterogeneous with respect to symptoms,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drevets, Wayne C., Wittenberg, Gayle M., Bullmore, Edward T., Manji, Husseini K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763135/ https://www.ncbi.nlm.nih.gov/pubmed/35039676 http://dx.doi.org/10.1038/s41573-021-00368-1

Ejemplares similares

Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
por: Wittenberg, Gayle M., et al.
Publicado: (2019)

Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder
por: Leday, Gwenaël G.R., et al.
Publicado: (2018)

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
por: Ionescu, Dawn F, et al.
Publicado: (2020)

Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders
por: Sun, Yu, et al.
Publicado: (2016)

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
por: Yang, Anna, et al.
Publicado: (2021)

Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.
por: Chen, Guang, et al.
Publicado: (2022)

Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders
por: Quiroz, Jorge A., et al.
Publicado: (2002)

Combining targeted therapeutics in the era of precision medicine
por: Papadatos-Pastos, D, et al.
Publicado: (2015)

Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine
por: Coppo, Paul, et al.
Publicado: (2018)

Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs
por: Le-Niculescu, H., et al.
Publicado: (2019)

Harnessing digital technology to predict, diagnose, monitor, and develop treatments for brain disorders
por: Stroud, Clare, et al.
Publicado: (2019)

Toward Precision Medicine in ADHD
por: Buitelaar, Jan, et al.
Publicado: (2022)

Treatment-resistant depression and peripheral C-reactive protein
por: Chamberlain, Samuel R., et al.
Publicado: (2019)

Editorial: Neural circuits and neuroendocrine mechanisms of major depressive disorder and premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
por: Wei, Sheng, et al.
Publicado: (2022)

Editorial: Neural circuits and neuroendocrine mechanisms of depression and premenstrual dysphoric disorder: towards precise targets for translational medicine and drug development, volume II
por: Wei, Sheng, et al.
Publicado: (2023)

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2023)

The role of anxious distress in immune dysregulation in patients with major depressive disorder
por: Gaspersz, Roxanne, et al.
Publicado: (2017)

Toward precision therapeutics: general and specific factors differentiate symptom change in depressed adolescents
por: Aitken, Madison, et al.
Publicado: (2020)

Toward precision medicine of breast cancer
por: Carels, Nicolas, et al.
Publicado: (2016)

Towards precision medicine for sepsis patients
por: Pickkers, Peter, et al.
Publicado: (2017)

Toward precision medicine in myotonic syndromes
por: De Bellis, Michela, et al.
Publicado: (2017)

Towards precision medicine in thyroid cancer
por: Xiao, Haipeng, et al.
Publicado: (2020)

Editorial: “Toward Precision Medicine in Vasculitis”
por: Alberici, Federico, et al.
Publicado: (2020)

Attitudes toward genomics and precision medicine
por: DuBois, James M., et al.
Publicado: (2021)

A decade of Genome Medicine: toward precision medicine
por: Begum, Rabia
Publicado: (2019)

Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine
por: Colman, Ruben J., et al.
Publicado: (2021)

Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision Medicine
por: Casadio, Marco, et al.
Publicado: (2021)

Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets
por: Badimon, Lina, et al.
Publicado: (2022)

Allele-specific genome targeting in the development of precision medicine
por: Wu, Junjiao, et al.
Publicado: (2020)

Targeted Therapies and Developing Precision Medicine in Gastric Cancer
por: Pihlak, Rille, et al.
Publicado: (2023)

Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies
por: Zeisberg, Michael, et al.
Publicado: (2015)

RNA Therapeutics in Cardiovascular Precision Medicine
por: Laina, Ageliki, et al.
Publicado: (2018)

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
por: Fedgchin, Maggie, et al.
Publicado: (2019)

No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing
por: Cole, John J., et al.
Publicado: (2021)

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial
por: Savitz, Jonathan, et al.
Publicado: (2012)

Toward Precision Medicine: How Far Is the Goal?
por: Ravegnini, Gloria, et al.
Publicado: (2016)

Pharmacometabolomics Informs Viromics toward Precision Medicine
por: Balasopoulou, Angeliki, et al.
Publicado: (2016)

Towards Precision Medicine in Systemic Lupus Erythematosus
por: Lever, Elliott, et al.
Publicado: (2020)

Editorial: Cancer Informatics Toward Precision Medicine
por: Zhang, Fan, et al.
Publicado: (2020)

Toward precision medicine in inflammatory breast cancer
por: Viale, Giulia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cf541fv9cdjqvgddg1djfj6do3